Vice President Scientific and Clinical Operations Virtual POC discovery performance unit
GlaxoSmithKline
After receiving her Ph.D. in Molecular and Cell Biology in Singapore, Coreen came to the US to pursue a post-doctoral fellowship at the Howard Hughes Medical Institute and the Department of Surgical Oncology at Duke University in cancer and HIV/AIDS vaccines.
Coreen joined GlaxoSmithKline in 2001 as a Clinical Research Scientist managing early phase oncology studies in the Clinical Sciences and Study Operations (CSSO) group. She assumed positions of increasing responsibility within GSK including Director of the Oncology and Infectious Diseases therapy areas. In Feb 2007, she was appointed to the role of Vice President, CSSO, where she was accountable for delivery of Phase 1 and 2 studies across all therapeutic areas in GSK. Coreen is currently Vice President, Scientific and Clinical Operations in the Virtual PoC DPU, where she is responsible for the externalization of early phase clinical development activities.
Appearing:
Day 2 - Thursday 4 February 2010
2pm
Case study: outsourcing of early phase clinical development activities – perspective from a large pharma virtual group
• GSK’s small expert virtual team progresses projects from target selection to phase 2A PoC mainly through using external CRO partners
Jane Clarke
